- Report
- January 2024
- 145 Pages
Global
From €5529EUR$5,565USD£4,597GBP
€7898EUR$7,950USD£6,567GBP
- Drug Pipelines
- January 2024
- 136 Pages
Global
From €5216EUR$5,250USD£4,337GBP
€7451EUR$7,500USD£6,195GBP
- Report
- February 2024
- 110 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- September 2024
- 181 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- September 2024
- 188 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- July 2024
- 180 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- June 2024
- 183 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- May 2024
- 182 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- May 2024
- 182 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- February 2024
- 184 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- October 2024
- 140 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- August 2024
- 168 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- March 2024
- 161 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- December 2023
- 158 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- December 2023
- 177 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- March 2024
- 200 Pages
Global
From €4123EUR$4,150USD£3,428GBP
- Report
- September 2024
- 250 Pages
Global
From €4966EUR$4,999USD£4,129GBP
The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more